en English

Panic Attack Treatment Market by 2028

Panic Attack Treatment Market is growing at a CAGR of 6.90% in the above-mentioned research forecast period

The panic attack treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 6.90% in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of the panic attack treatment market.

Request For a Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-panic-attack-treatment-market

Panic attacks are characterized by the sudden wave of fear in the people. When people suffer from panic attacks, they feel as they are unable to breathe and are having heart attacks. These panic attacks mainly occur one or two times but sometimes it may be for a longer period of time. Panic attacks can also lead to other disorders such as phobia, anxiety, depression and many others. Symptoms for the panic attacks are shortness of breath, chest pain, fear of dying, nausea, sweating and many more symptoms. There is no cure for the panic attacks and the medications and therapies work on 80% of patient’s population and 20% still suffer from the symptoms and have to live with these attacks.

The rise in prevalence of lifetime panic disorder and patients with panic disorder having life time problems of anxiety, depression, cardiovascular, respiratory, gastrointestinal and other problems such as obsessive compulsion disorder, COPD, asthma and social phobia may drive the panic attack treatment market growth. For instance, according to Anxiety and Depression Association of America, there are 6 million adults in the U.S. suffering from panic disorders in 2020.

Increasing healthcare expenditure and support from the government are the opportunities for the panic attack treatment market growth. Challenging factor for the panic attack treatment market growth is the risk factors that are some of the patient population are at high risk if they take the medications for the panic attacks such as older population, pregnant women, bipolar disease patient and young population. So, it is very difficult for the physicians to provide them with a treatment of panic attacks.

On geographical estimation, North America accounts the largest market share because of increasing prevalence of neurological disorders such as panic attacks, increase in number of FDA approval drugs and high awareness about the anxiety and depression. Asia-Pacific holds the second largest share due to change in lifestyle which led to the stress and depression resulted in panic disorders.

The major players covered in the global panic attack treatment market report are Teva Pharmaceutical Inc., Sun Pharmaceutical Industries Ltd, Mylan N.V., AstraZeneca, Abbott Laboratories, Actavis Pharmaceutical Company, Baxter International, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Noven Pharmaceuticals, Inc., Pfizer, Inc., Recordati Rare Diseases, Shionogi and Company, Sumitomo Dainippon Pharma, Torrent Pharmaceuticals Ltd, Sanofi among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com